DRD1 and Parkinson disease: The identification of specific genes whose expression is increased upon prolonged treatment with L-DOPA and dopamine D1 receptor stimulation offer a possibility to design novel therapeutic strategies to treat Parkinson's disease and potentially other disorders caused by dysfunctional dopaminergic transmission in the brain, such as drug addiction and schizophrenia.